These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32021611)

  • 1. Neurodegenerative Disease-Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain.
    Dean HB; Roberson ED; Song Y
    Front Neurol; 2019; 10():1252. PubMed ID: 32021611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic insights into the effects of nonsynonymous polymorphisms (nsSNPs) on loss of TREM2 function.
    Dash R; Munni YA; Mitra S; Choi HJ; Jahan SI; Chowdhury A; Jang TJ; Moon IS
    Sci Rep; 2022 Jun; 12(1):9378. PubMed ID: 35672339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM2 variants that cause early dementia and increase Alzheimer's disease risk affect gene splicing.
    Kiianitsa K; Lukes ME; Hayes BJ; Brutman JN; Valdmanis PN; Bird TD; Raskind WH; Korvatska O
    Brain; 2024 Jul; 147(7):2368-2383. PubMed ID: 38226698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
    Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
    Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
    Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A
    Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
    Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
    J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous TREM2 mutations in frontotemporal dementia.
    Borroni B; Ferrari F; Galimberti D; Nacmias B; Barone C; Bagnoli S; Fenoglio C; Piaceri I; Archetti S; Bonvicini C; Gennarelli M; Turla M; Scarpini E; Sorbi S; Padovani A
    Neurobiol Aging; 2014 Apr; 35(4):934.e7-10. PubMed ID: 24139279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coding variants in TREM2 increase risk for Alzheimer's disease.
    Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
    Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational saturation mutagenesis to explore the effect of pathogenic mutations on extra-cellular domains of TREM2 associated with Alzheimer's and Nasu-Hakola disease.
    Swain PS; Panda S; Pati S; Dehury B
    J Mol Model; 2023 Nov; 29(11):360. PubMed ID: 37924367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights into the deleterious roles of Nasu-Hakola disease associated TREM2 variants.
    Dash R; Choi HJ; Moon IS
    Sci Rep; 2020 Feb; 10(1):3663. PubMed ID: 32107424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
    Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
    Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.
    Sudom A; Talreja S; Danao J; Bragg E; Kegel R; Min X; Richardson J; Zhang Z; Sharkov N; Marcora E; Thibault S; Bradley J; Wood S; Lim AC; Chen H; Wang S; Foltz IN; Sambashivan S; Wang Z
    J Biol Chem; 2018 Aug; 293(32):12634-12646. PubMed ID: 29794134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Alzheimer's Disease-Associated R47H Variant of TREM2 Has an Altered Glycosylation Pattern and Protein Stability.
    Park JS; Ji IJ; Kim DH; An HJ; Yoon SY
    Front Neurosci; 2016; 10():618. PubMed ID: 28149270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.
    Kleinberger G; Brendel M; Mracsko E; Wefers B; Groeneweg L; Xiang X; Focke C; Deußing M; Suárez-Calvet M; Mazaheri F; Parhizkar S; Pettkus N; Wurst W; Feederle R; Bartenstein P; Mueggler T; Arzberger T; Knuesel I; Rominger A; Haass C
    EMBO J; 2017 Jul; 36(13):1837-1853. PubMed ID: 28559417
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Kiralyova I; Sutovsky S; Petrovic R; Shawkatova I
    J Integr Neurosci; 2022 Jun; 21(4):105. PubMed ID: 35864757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms.
    Kober DL; Alexander-Brett JM; Karch CM; Cruchaga C; Colonna M; Holtzman MJ; Brett TJ
    Elife; 2016 Dec; 5():. PubMed ID: 27995897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimerization of TREM2 is impaired by Alzheimer's disease-associated variants.
    Dean HB; Greer RA; Yang SZ; Elston DS; Brett TJ; Roberson ED; Song Y
    Alzheimers Dement; 2024 Jul; ():. PubMed ID: 39032157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression.
    Sirkis DW; Bonham LW; Aparicio RE; Geier EG; Ramos EM; Wang Q; Karydas A; Miller ZA; Miller BL; Coppola G; Yokoyama JS
    Acta Neuropathol Commun; 2016 Sep; 4(1):98. PubMed ID: 27589997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 Gene Compound Heterozygosity in Neurodegenerative Disorders.
    Berdyński M; Ludwiczak J; Barczak A; Barcikowska-Kotowicz M; Kuźma-Kozakiewicz M; Dunin-Horkawicz S; Żekanowski C; Borzemska B
    J Alzheimers Dis; 2022; 89(4):1211-1219. PubMed ID: 36031890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.
    Cheng-Hathaway PJ; Reed-Geaghan EG; Jay TR; Casali BT; Bemiller SM; Puntambekar SS; von Saucken VE; Williams RY; Karlo JC; Moutinho M; Xu G; Ransohoff RM; Lamb BT; Landreth GE
    Mol Neurodegener; 2018 Jun; 13(1):29. PubMed ID: 29859094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.